[Use of the stimulants of nonspecific resistance in the complex treatment of infectious complications in patients with chronic myeloid leukemia].
Effectiveness of three methods of infectious complication therapy in chronic myeloleukemia (CML) patients was studied. Group I patients (n = 20) received antibiotics, group II patients (n = 9) were given antibiotics with gamma-globulin, in group III antibiotics combined with individually selected immunomodulators were used. The highest effect was recorded in CML patients who received antibiotics combined with the immunomodulators that has led to normalization of cellular and humoral factors of nonspecific body resistance.
Guseva
S A
SA
D000276:Adjuvants, Immunologic; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007116:Immunization, Passive; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology*; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology*; D009894:Opportunistic Infections / Q000209:etiology / Q000628:therapy*; D011354:Prodigiozan / Q000008:administration & dosage*; D012141:Respiratory Tract Infections / Q000209:etiology / Q000628:therapy*; D015054:Zymosan / Q000008:administration & dosage*; D005719:gamma-Globulins / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D005719:gamma-Globulins; D015054:Zymosan; D011354:Prodigiozan
Primenenie stimuliatorov nespetsificheskoĭ rezistentnosti organizma v kompleksnom lechenii infektsionnykh oslozhneniĭ u bol'nykh khronicheskim mieloleĭkozom.